Kequan Xu
- Topics
- RNA modifications and cancer (12 papers)Cancer-related molecular mechanisms research (9 papers)RNA Research and Splicing (5 papers)
- Partner nations
- China
In The Last Decade
Kequan Xu
19 papers receiving 514 citations
Hit Papers
Peers
Comparison fields: 5 of 51
- Molecular Biology 387
- Cancer Research 287
- Pulmonary and Respiratory Medicine 99
- Oncology 85
- Immunology 46
Countries citing papers authored by Kequan Xu
This map shows the geographic impact of Kequan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kequan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kequan Xu more than expected).
Fields of papers citing papers by Kequan Xu
This network shows the impact of papers produced by Kequan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kequan Xu. The network helps show where Kequan Xu may publish in the future.
Co-authorship network of co-authors of Kequan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Kequan Xu. A scholar is included among the top collaborators of Kequan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kequan Xu. Kequan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 24 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progressionbreakdown → | 99 |
| 6 | 1 | |
| 7 | 19 | |
| 8 | 25 | |
| 9 | 4 | |
| 10 | 7 | |
| 11 | 12 | |
| 12 | 17 | |
| 13 | 20 | |
| 14 | 38 | |
| 15 | 20 | |
| 16 | 4 | |
| 17 | 171 | |
| 18 | 34 | |
| 19 | 17 |
About Kequan Xu
Kequan Xu is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 19 papers that have together received 517 indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (9 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Cancer Research (287 citations), Molecular Biology (387 citations) and Oncology (85 citations). Kequan Xu has collaborated with scholars based in China. Frequent co-authors include Yufeng Yuan, Hao Zhang, Peng Xia, Weijie Ma, Xi Chen, Zhonglin Zhang, Xiang Jiang, Peng Xia, Meng Gao and Ye Yao. Their work appears in journals such as The Science of The Total Environment, Hepatology and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.